RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN COMBINATION WITH LOW-DOSE RITUXIMAB (LD RTX) IN SEVERE OR REFRACTORY PRIMARY IMMUNE THROMBOCYTOPENIA: A MULTICENTER PROSPECTIVE CLINICAL TRIAL

被引:0
|
作者
Hou, M. [1 ]
Xu, M. [1 ]
Peng, J. [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Hematol, Jinan, Shandong, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P466
引用
收藏
页码:196 / 196
页数:1
相关论文
共 17 条
  • [1] Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study
    Liu, Xiaofan
    Bai, Yusheng
    Wang, Tao
    Song, Yanping
    Sun, Feng
    Xia, Ruixiang
    Zhu, Feiyue
    Ma, Jun
    Lu, Quanyi
    Ye, Xu
    Zhan, Xinrong
    Li, Linjie
    Guo, Xinhong
    Cheng, Shuqin
    Li, Yan
    Guo, Zhiqiang
    Chen, Youhua
    Qian, Shenxian
    Qin, Ling
    Zhang, Qing
    Cao, Sunqiong
    Yang, Renchi
    PLATELETS, 2023, 34 (01)
  • [2] Efficacy of low-dose rituximab in combination with recombinant human thrombopoietin in treating ITP
    Li, Y.
    Wang, Y. -Y.
    Fei, H. -R.
    Wang, L.
    Yuan, C. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (09) : 1583 - 1588
  • [3] Refractory immune thrombocytopenia treated with low-dose decitabine combined with recombinant human thrombopoietin or eltrombopag: Two case reports
    Jiang, Yuxia
    Xu, Yani
    Wu, Haiying
    He, Minxia
    Jiang, Huifang
    Xu, Xiaofeng
    MEDICINE, 2025, 104 (06)
  • [4] A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia
    Wang, Shujie
    Yang, Renchi
    Zou, Ping
    Hou, Ming
    Wu, Depei
    Shen, Zhixiang
    Lu, Xijing
    Li, Yan
    Chen, Xiequn
    Niu, Ting
    Sun, Hui
    Yu, Li
    Wang, Zhao
    Zhang, Yin
    Chang, Naibai
    Zhang, Gaokui
    Zhao, Yongqiang
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (02) : 222 - 228
  • [5] A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia
    Shujie Wang
    Renchi Yang
    Ping Zou
    Ming Hou
    Depei Wu
    Zhixiang Shen
    Xijing Lu
    Yan Li
    Xiequn Chen
    Ting Niu
    Hui Sun
    Li Yu
    Zhao Wang
    Yin Zhang
    Naibai Chang
    Gaokui Zhang
    Yongqiang Zhao
    International Journal of Hematology, 2012, 96 : 222 - 228
  • [6] Refractory immune thrombocytopenia responding to combination therapy of eltrombopag and low-dose rituximab: a case series
    Chu, Tan-Huy
    Huynh, Thien-Ngon
    Trinh-Le, Quoc-Vu
    Phu, Chi-Dung
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S299 - S304
  • [7] Recombinant Human Thrombopoietin and Rituximab vs Rituximab Monotherapy in Corticosteroid-Resistant Primary Immune Thrombocytopenia: a Multicenter Randomized Controlled Study
    Xu, Miao
    Qin, Ping
    Dong, Xiaoyuan
    Li, Jie
    Zhang, Haiyan
    Wang, Xin
    Meng, Yuesheng
    Yuan, Chenglu
    Zhao, Hongguo
    Peng, Jun
    Hou, Ming
    BLOOD, 2013, 122 (21)
  • [9] Optimized Recombinant Human Thrombopoietin(rhTPO) Regimen Versus Eltrombopag for Pre-Treated Patients with Primary Immune Thrombocytopenia: Interim Results from a Prospective, Multicenter, Randomized Trial (TE-ITP study)
    Chen, Yunfei
    Sun, Ting
    Gao, Da
    Wang, Wei
    Zhou, Zeping
    Gao, Guangxun
    Wang, Yi
    Zhou, Hu
    Song, Yanping
    Lai, Yinghui
    Yan, Zhenyu
    Yan, Jinsong
    Hai, Jie
    Zhang, Lei
    BLOOD, 2024, 144 : 3937 - 3938
  • [10] The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG Monotherapy-Resistant Immune Thrombocytopenia in Pregnancy
    He, Yun
    Fu, Haixia
    Zhu, Xiaolu
    Huang, Qiusha
    Chen, Qi
    Wu, Jin
    Chen, Yuxiu
    Zhao, Peng
    Liu, Kai-Yan
    Zhang, Xiaohui
    BLOOD, 2023, 142